Ameritas Investment Partners’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-104
| Closed | -$2.79K | – | 3254 |
|
|
2023
Q1 | $2.79K | Hold |
104
| – | – | ﹤0.01% | 2936 |
|
|
2022
Q4 | $4.41K | Hold |
104
| – | – | ﹤0.01% | 2941 |
|
|
2022
Q3 | $23K | Buy |
104
+35
| +51% | +$7.74K | ﹤0.01% | 2470 |
|
|
2022
Q2 | $13K | Hold |
69
| – | – | ﹤0.01% | 2768 |
|
|
2022
Q1 | $17K | Hold |
69
| – | – | ﹤0.01% | 2635 |
|
|
2021
Q4 | $11K | Hold |
69
| – | – | ﹤0.01% | 2882 |
|
|
2021
Q3 | $14K | Hold |
69
| – | – | ﹤0.01% | 2855 |
|
|
2021
Q2 | $18K | Hold |
69
| – | – | ﹤0.01% | 2799 |
|
|
2021
Q1 | $18K | Hold |
69
| – | – | ﹤0.01% | 2618 |
|
|
2020
Q4 | $25K | Hold |
69
| – | – | ﹤0.01% | 2364 |
|
|
2020
Q3 | $17K | Hold |
69
| – | – | ﹤0.01% | 2474 |
|
|
2020
Q2 | $20K | Hold |
69
| – | – | ﹤0.01% | 2351 |
|
|
2020
Q1 | $14K | Hold |
69
| – | – | ﹤0.01% | 2383 |
|
|
2019
Q4 | $31K | Hold |
69
| – | – | ﹤0.01% | 2186 |
|
|
2019
Q3 | $21K | Hold |
69
| – | – | ﹤0.01% | 2374 |
|
|
2019
Q2 | $22K | Buy |
+69
| New | +$22K | ﹤0.01% | 2401 |
|
|
2017
Q2 | – | Sell |
-9
| Closed | -$3K | – | 3063 |
|
|
2017
Q1 | $3K | Buy |
+9
| New | +$3K | ﹤0.01% | 2907 |
|